Literature DB >> 16647883

HIV integration site selection: targeting in macrophages and the effects of different routes of viral entry.

Stephen D Barr1, Angela Ciuffi, Jeremy Leipzig, Paul Shinn, Joseph R Ecker, Frederic D Bushman.   

Abstract

We have studied the selection of HIV DNA integration sites in primary macrophages to investigate two questions. First, mature macrophages do not divide, allowing us to investigate whether HIV integration targeting differs between dividing cells and nondividing cells. We sequenced and analyzed 754 unique integration sites and found that integration in macrophages is favored in active transcription units (TUs), as was observed previously for other cell types. However, HIV integration in genes was slightly less favored in macrophages than in dividing PBMC or T cell lines. Second, we compared integration targeting by HIV-vector particles bearing either of two different envelope proteins (HIV R5 Env or VSV-G) to determine whether the mechanism of entry influenced subsequent integration targeting. Integration sites generated by HIV R5- or VSV-G-bearing particles showed no significant differences in their distributions in the human genome. Analysis of additional published integration site sequences also indicated that the route of entry did not affect integration site selection for other viral envelopes as well.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16647883     DOI: 10.1016/j.ymthe.2006.03.012

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  48 in total

Review 1.  HIV DNA integration.

Authors:  Robert Craigie; Frederic D Bushman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

2.  HIV integration site selection: analysis by massively parallel pyrosequencing reveals association with epigenetic modifications.

Authors:  Gary P Wang; Angela Ciuffi; Jeremy Leipzig; Charles C Berry; Frederic D Bushman
Journal:  Genome Res       Date:  2007-06-01       Impact factor: 9.043

Review 3.  Nucleocapsid protein function in early infection processes.

Authors:  James A Thomas; Robert J Gorelick
Journal:  Virus Res       Date:  2008-02-14       Impact factor: 3.303

4.  Analysis of lentiviral vector integration in HIV+ study subjects receiving autologous infusions of gene modified CD4+ T cells.

Authors:  Gary P Wang; Bruce L Levine; Gwendolyn K Binder; Charles C Berry; Nirav Malani; Gary McGarrity; Pablo Tebas; Carl H June; Frederic D Bushman
Journal:  Mol Ther       Date:  2009-03-03       Impact factor: 11.454

5.  Dotting the I's and crossing the T's: integration analyses in transduced patient T cells.

Authors:  John J Rossi
Journal:  Mol Ther       Date:  2009-05       Impact factor: 11.454

6.  Nondividing cells: a safer bet for integrating vectors?

Authors:  Troy Brady; Frederic D Bushman
Journal:  Mol Ther       Date:  2011-04       Impact factor: 11.454

Review 7.  Genotoxicity of retroviral hematopoietic stem cell gene therapy.

Authors:  Grant D Trobridge
Journal:  Expert Opin Biol Ther       Date:  2011-03-07       Impact factor: 4.388

8.  Retrotransposon Ty1 integration targets specifically positioned asymmetric nucleosomal DNA segments in tRNA hotspots.

Authors:  Loris Mularoni; Yulian Zhou; Tyson Bowen; Sunil Gangadharan; Sarah J Wheelan; Jef D Boeke
Journal:  Genome Res       Date:  2012-01-04       Impact factor: 9.043

9.  Lentiviral integration preferences in transgenic mice.

Authors:  Shang-Hsun Yang; Pei-Hsun Cheng; Robert T Sullivan; James W Thomas; Anthony W S Chan
Journal:  Genesis       Date:  2008-12       Impact factor: 2.487

10.  Feline leukemia virus integrase and capsid packaging functions do not change the insertion profile of standard Moloney retroviral vectors.

Authors:  J-Y Métais; S Topp; R T Doty; B Borate; A-D Nguyen; T G Wolfsberg; J L Abkowitz; C E Dunbar
Journal:  Gene Ther       Date:  2010-03-18       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.